men's health Flashcards
post-void residual normal and abnormal volumes
normal is less than 50-100
abnormal is over 200
normal and abnormal urine velocity
normal is 20-25 ml/sec
abnormal is less than 12-15 ml/sec
neurologic control of bladder
PSNS (ACh, M3) causes detrusor constriction and bladder emptying
SNS (adrenergic) facilitates urine storage (B2 and B3-R in detrusor -> relaxation; alpha-1 in internal sphincter -> contraction)
somatic control via pudendal nerve
behavioral modifications for tx of urinary incontinence
toilet assistance - regular scheduling, caregiver
bladder training - education, scheduled voiding, positive reinforcement
pelvic mm rehab (Kegel)
biofeedback
MOA of drugs for overactive bladder
stop spontaneous detrusor contractions - anti-ACh
differences in drugs for OAB
muscarinic receptor specificity, lipophilicty (CNS effects), metabolism, and dosage form
oxybutinin
anti-ACh for OAB
most ACh ADRs (dry mouth, etc.)
available short- and long-acting oral tabs, transdermal patches, topical gel
tolterodine
anti-ACh for OAB
more selective M3-blocker vs oxybutinin
trospium
anti-ACh for OAB
fesoteridine
anti-ACh for OAB
solifenacin
anti-ACh for OAB
darifenacin
anti-ACh for OAB
mirebegron
first oral B3 agonist for OAB
onabotulinumtoxinA
injected into detrusor during cystoscopy to block ACh release at NMJ for OAB
lasts 19-24 weeks
drugs that can cause or exacerbate urinary incontinence
urinary retention: anti-ACh, anti-depressants, anti-psychotics, B-agonists, CCB, opioids
polyuria, freq, urgency: EtOH, caffeine, diuretics
urethral relax: a-blockers
mm relaxer: sedatives, hypnotics
tissues of prostate
epithelial/ glandular: makes secretions, under androgen control
stroma: SM with a1-receptors
5-a-reductase
converts testosterone to DHT in prostate, beginning at puberty -> rapid growth and enlargement of prostate